HSBC TUR.WAR.OP.END. ICY/ DE000HG9LGD3 /
10/10/2024 9:37:17 PM | Chg.-0.0800 | Bid9:59:45 PM | Ask9:59:45 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.6300EUR | -4.68% | 1.6500 Bid Size: 30,000 |
1.6800 Ask Size: 30,000 |
Incyte Corporation | 47.5059 USD | 12/31/2078 | Call |
GlobeNewswire
8/16
China Medical System (00867) Released its 2024 Interim Results: Steady Increase in Revenue and Profi...
GlobeNewswire
8/6
MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire
8/1
Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire
7/30
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboratio...
GlobeNewswire
6/25
China Medical System Completes Dosing of the First Subject in Phase III Bridging Trial of Ruxolitini...
GlobeNewswire
5/9
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim ...
GlobeNewswire
5/8
Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update
GlobeNewswire
4/2
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sin...
GlobeNewswire
4/1
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast ...
GlobeNewswire
2/28
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Up...
GlobeNewswire
1/9
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
12/9/2023
CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program
GlobeNewswire
11/16/2023
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition progr...
GlobeNewswire
11/2/2023
Merus Announces Financial Results for the Third Quarter 2023 and Provides Business Update